Mark G. Shrime, instructor in otology and laryngology at Massachusetts Eye and Ear, and John G. Meara, professor of global health and social medicine and professor of surgery at Boston Children’s Hospital, co-authored this article on global poverty.
This week, a controversy was ignited after Turing Pharmaceuticals chief executive Martin Shkreli hiked the price for his drug Daraprim by 4,000 percent. Aaron Kesselheim, associate professor of medicine at Brigham and Women’s Hospital, is quoted.
New studies of two drugs, showing that each works better than the standard treatment for advanced kidney cancer, should lead to changes in patient care, researchers said on Friday. Toni Choueiri, associate professor of medicine at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, is quoted.
A 13-year-old birth control implant came under new scrutiny Thursday as federal health experts discussed a host of problems reported by women implanted with the metallic device, including chronic pain, bleeding and fatigue. Peter Schalock, associate professor of dermatology at Massachusetts General Hospital, is quoted.
Thanks to a $30 million funding deal, meditation app “Headspace” could soon join the ranks of innovative workplace wellness perks some companies offer employees. Ateev Mehrotra, associate professor of health care policy, is quoted.